Search results
Cancer death rates are dropping, but not for everyone
Scripps News via AOL· 20 hours agoUnfortunately, a number of health disparities remain, such as: Black men are twice as likely to die...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 8 hours agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
His Cancer Journey Shows Health Dangers Firefighters Face
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoFor 14 years, David Perez fought fires in South Florida, thinking he was in peak physical shape. “I...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks· 15 hours agoFree Report) announced that the FDA has granted accelerated approval to the label expansion of chimeric antigen receptor (CAR) T cell therapy Breyanzi (lisocabtagene maraleucel; liso-cel). The ...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Hi-Desert Star· 2 days agoExpanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeting solid tumors
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
BioPharma Dive via Yahoo Finance· 9 hours agoThe deal is part of a plan by J&J to build a portfolio of “differentiated” bispecific antibodies, an...
Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales
Morningstar· 3 days agoBy Dean Seal Legend Biotech narrowed its loss in the first quarter as revenue climbed on higher sales of its multiple myeloma treatment Carvykti. The cell ...
Benjamin F. Edwards & Company Inc. Buys Shares of 542 BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 4 days agoBenjamin F. Edwards & Company Inc. purchased a new stake in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities ...
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Zacks· 15 hours agoA month has gone by since the last earnings report for Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) . Will the recent positive trend continue leading up to its next earnings release, ...
These 2 No-Brainer Growth Stocks Are Breaking New Ground | The Motley Fool
The Motley Fool· 9 hours agoEli Lilly (LLY -1.39%) and Regeneron Pharmaceuticals (REGN -0.21%) have historically been in the...